Global intelligence for effective trial strategies

Efficiently get your drug through the clinical phases.

Discover unmet needs in rare diseases and niche patient populations, conduct advanced patient stratification, keep track of medical device trials and all trials involving biomarkers, leverage clinical informatics, and evaluate the competitive landscape. Cortellis Clinical Trials Intelligence provides expertly curated clinical trials information skillfully integrated with other scientific and competitive intelligence from Thomson Reuters.

With comprehensive coverage of clinical trials and rare diseases, gene variant and biomarker indexing, and links to biomarker and ontology APIs, Cortellis Clinical Trials Intelligence goes above and beyond competitive solutions. And that's before we mention our industry partnerships, data delivery via API, and tight collaboration with our discovery and professional services teams.

Features & Benefits

  • Search and analyze more than 230,000 US and global trials from multiple registries
  • Narrow patient segmentation of clinical trials, and examine comprehensive coverage of rare disease clinical trials
  • Enhance clinical informatics projects with actionable global clinical trials information and integrate clinical and research programs via links to the Cortellis Biomarker API and Thomson Reuters Integrity
  • Best in class web portal provides filtering options for enhanced searches and robust alerting and exporting features while leveraging standardized ontology

Related Blog Posts

20 November, 2016

FDA approval and regulation of medical devices: a primer

Regulatory Affairs
20 November, 2016

When competitive intelligence is predictive rather than reactive, biopharma companies can grab the edge

Research and Development
20 November, 2016

NGS, maybe, sort of, sometimes clinic ready

Research and Development